Canada markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1980+0.0040 (+2.06%)
At close: 01:00PM EST
0.1900 -0.01 (-4.04%)
After hours: 04:21PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.88M
Enterprise Value 3.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.28
Price/Book (mrq)1.26
Enterprise Value/Revenue 0.46
Enterprise Value/EBITDA -0.06

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 3-99.13%
S&P500 52-Week Change 3-13.51%
52 Week High 329.6000
52 Week Low 30.1830
50-Day Moving Average 30.2683
200-Day Moving Average 33.0543

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 3856.86k
Shares Outstanding 540.61M
Implied Shares Outstanding 6N/A
Float 837.41M
% Held by Insiders 17.84%
% Held by Institutions 15.72%
Shares Short (Nov 14, 2022) 41.09M
Short Ratio (Nov 14, 2022) 40.85
Short % of Float (Nov 14, 2022) 42.68%
Short % of Shares Outstanding (Nov 14, 2022) 42.68%
Shares Short (prior month Oct 13, 2022) 41.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Apr 26, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)-677.39%

Management Effectiveness

Return on Assets (ttm)-129.01%
Return on Equity (ttm)-791.13%

Income Statement

Revenue (ttm)8.4M
Revenue Per Share (ttm)0.70
Quarterly Revenue Growth (yoy)133.30%
Gross Profit (ttm)-6.62M
Net Income Avi to Common (ttm)-67.01M
Diluted EPS (ttm)-26.1610
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.14M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)2.15M
Total Debt/Equity (mrq)34.26
Current Ratio (mrq)1.33
Book Value Per Share (mrq)0.16

Cash Flow Statement

Operating Cash Flow (ttm)-51.01M
Levered Free Cash Flow (ttm)-34.63M